Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers

Cancer

Volumn 106, Issue 8, 2006, Pages 1766-1775

  Sartori, Francesca ^a   Alaggio, Rita ^b   Zanazzo, Giulio ^c   Garaventa, Alberto ^d   Di Cataldo, Andrea ^e   Carli, Modesto ^a   Rosolen, Angelo ^a,f  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f Dipartimento di Pediatria   (Italy)

Author keywords

Bone marrow; MRD; MyoD1; Rhabdomyosarcoma; RT PCR

Indexed keywords

ANTINEOPLASTIC AGENT; MOLECULAR MARKER; MYOD1 PROTEIN; MYOGENIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; TUMOR MARKER;

ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; INTERMETHOD COMPARISON; METASTASIS; MICROSCOPY; MINIMAL RESIDUAL DISEASE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

BONE MARROW NEOPLASMS; CHILD; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MYOD PROTEIN; MYOGENIN; PAIRED BOX TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33646041022     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21772     Document Type: Article

References (25)

1. Wexler LH, Crist WM, Helman LJ. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:939-962.
2. Tsokos M. The diagnosis and classification of childhood rhabdomyosarcoma. Semin Diagn Pathol 1998;11:26-38.
3. Parham DM. The molecular biology of childhood rhabdomyosarcoma. Semin Diagn Pathol. 1994;11:39-46.
4. Pappo AS, Shapiro DN, Crist WM, et al. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol. 1995;13:2123-2139.
5. Fey MF, Kulozik AE, Hansen-Hagge TE, et al. The polymerase chain reaction: a new tool for the detection of minimal residual disease in haematological malignancies. Eur J Cancer. 1991;27:89-94.
6. Sebire, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol. 2003;56:412-416.
7. Cui S, Hano H, Harada T, Takai S, Masui F, Ushigome S. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Pathol Int. 1999;49:62-68.
8. Dias P, Chen B, Dilday B, Palmer H, et al. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumours of the alveolar subclass. Am J Pathol. 2000;156:399-408.
9. Folpe AL, McKenney JK, Brige JA, et al. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002;26:1175-1183.
10. Frascella E, Rosolen A. Detection of MyoD1 transcript in rhabdomyosarcoma cell line and tumor samples by reverse transcription polymerase chain reaction. Am J Pathol. 1998;152:577-583.
11. Gattenloehner S, Dockhorn-Dworniczak B, Leuschner I, et al. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues. J Mol Diagn. 1999;1:23-31.
12. Gattenloehner S, Vincent A, Leuschner I, et al. The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other chilhood tumors. Am J Pathol. 1998;152:437-444.
13. Michelagnoli MP, Burchill SA, Cullinane C, et al. Myogenin- a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1. Med Pediatr Oncol. 2003;40:1-8.
14. Sorensen PHB, Lynch JC, Stephen JQ, et al. PAX3-FKHR and PAX7-FKHR gene fusion are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol. 2002;20:2672-2679.
15. Anderson J, Gordon T, McManus A, et al. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer. 2001;85:831-835.
16. Galili N, Davis RJ, Fredericks WJ, et al. Fusion of a fork head domain gene to PAX 3 in the solid tumour alveolar rhabdomyosacoma. Nature Genet. 1993;5:230-235.
17. Barr FG. Molecolar genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol. 1997;19:483-491.
18. Gattenlohner S, Muller-Hermelink H-K, Marx A. Polymerase chain reaction-based diagnosis of rhabdomyosarcomas: comparison of fetal type acetylcoholine receptor subunits and myogenin. Diagn Mol Pathol. 1998;7:129-134.
19. Bisogno G, Rossi L, Messina C, et al. Sequential high-dose chemotherapy in children with metastatic soft tissue sarcoma [abstract]. Med Pediatr Oncol. 2003;41:278.
20. Carli M, Cecchetto G, Sotti G, et al. Soft tissue sarcomas. In: Pinkerton R, Plowman PN, Pieters R, editors. Paediatric oncology: clinical practice and controversies, 3rd ed. London: Arnold Publishers; 2004:339-365.
21. Maurer HM, Gehan EA, Beltagrady M. The Intergroup Rhabdomyosarcoma Study-II. Cancer. 1993;71:1904-1922.
22. Ruymann FB, Newton WA Jr, Ragab AH, et al. Bone marrow metastases at diagnosis in children and adolescents with Rhabdomyosarcoma. Cancer. 1984;53:368-373.
23. Reilly A, Perilongo G, Chatten J, et al. Histologic subtype determines pattern of metastases in childhood rhabdomyosarcoma [abstract]. Proc Am Soc Clin Oncol. 1991;10:316. Abstract 111.
24. Kelly KM, Womer RB, Barr FG. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method. Cancer. 1996;78:1320-1327.
25. Clark J, Rocques PJ, Braun T, et al. Expression of members of the myf gene family in human rhabdomyosarcomas. Br J Cancer. 1991;64:1039-1042.